Signup Crypto ETF Stocks News

Talkdesk revolutionizes the way utilities companies deliver intelligent, seamless, and proactive customer experiences

PALO ALTO, Calif. and PHOENIX, May 05, 2025 ( GLOBE NEWSWIRE ) -- Talkdesk®, Inc., a global provider of artificial intelligence ( AI ) -powered customer experience ( CX ) technology that serves enterprises of all sizes, today introduced Talkdesk Utilities Experience Cloud™, an intelligent CX ...

Source: www.benzinga.com
May 05, 2025 | 13:50:32
Category: General

Long-Term Shareholders Have Rights - If You Hold Akero Therapeutics, Inc. ( NASDAQ: AKRO ) ; Integra Lifesciences Holdings Corporation ( NASDAQ: IART ) ; Mercury Systems, Inc. ( NASDAQ: MRCY ) ; or Virtu Financial Inc. ( NASDAQ: VIRT ) , Contact Grabar Law Office - Integra Lifesciences ( NASDAQ:IART ) , Akero Therapeutics ( NASDAQ:AKRO )

PHILADELPHIA, May 05, 2025 ( GLOBE NEWSWIRE ) -- Akero Therapeutics, Inc. AKRO: Grabar Law Office is investigating whether certain officers and directors of Akero breached their fiduciary duties owed to the company. If you have held Akero Therapeutics, Inc.

Source: www.benzinga.com
May 05, 2025 | 13:51:18
Category: News

Nasdaq Falls Over 100 Points; Tyson Foods Posts Downbeat Sales - Click Holdings ( NASDAQ:CLIK ) , DigiAsia ( NASDAQ:FAAS )

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Monday. Following the market opening Monday, the Dow traded down 0.38% to 41,158.62 while the NASDAQ fell 0.79% to 17,835.60. The S&P 500 also fell, dropping, 0.73% to 5,645.34.

Source: www.benzinga.com
May 05, 2025 | 13:54:58
Category: Trading

MicroStrategy Stock Rose Over 3% On Friday After Key Signal

MSTR climbs over 12 points higher after the alert from TradePulse MicroStrategy, Inc. ( MSTR ) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.

Source: www.benzinga.com
May 05, 2025 | 13:56:14
Category: Trading

Footwear Giant Skechers To Go Private At 30% Premium In PE Deal - Skechers USA ( NYSE:SKX )

Skechers to be acquired for $63 per share in cash. Company will go private following Q3 2025 transaction close. Learn the top momentum trading strategies for today's whipsaw market, live with Chris Capre on Sunday, May 4 at 1 PM ET. Reserve your free spot now. Footwear giant Skechers U.S.A. Inc.

Source: www.benzinga.com
May 05, 2025 | 13:58:14
Category: Trading

Invitation to Tallinna Sadam Investor Conference Webinar for the unaudited results of Q1 2025

AS Tallinna Sadam invites all the stakeholders to join its investor conference webinar, introducing the unaudited results for Q1 2025. The webinar is scheduled for 12 May 2025.

Source: www.globenewswire.com
May 05, 2025 | 14:00:00
Category: News

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act ( BlackRock, Inc. )

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS5 May 2025 at ...

Source: www.globenewswire.com
May 05, 2025 | 14:00:00
Category: News

K12 Tutoring Approved as Vendor for Oregon Department of Education's High-Dosage Tutoring Program

With this partnership, K12 Tutoring will deliver high-quality, individualized tutoring services to Oregon's students. With this partnership, K12 Tutoring will deliver high-quality, individualized tutoring services to Oregon's students.

Source: www.globenewswire.com
May 05, 2025 | 14:00:00
Category: News

GD Culture Group Limited Announces PIPE of approximately 5.5 Million

NEW YORK, May 05, 2025 ( GLOBE NEWSWIRE ) -- GD Culture Group Limited ( "GDC" or the "Company" ) ( Nasdaq: GDC ) , and its subsidiary, AI Catalysis Corp. ( "AI Catalysis" ) , today announced the signing of private placement ( the "Offering" ) on May 2, 2025 with several purchasers for the ...

Source: www.globenewswire.com
May 05, 2025 | 14:00:00
Category: News

Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference

BOSTON, May 05, 2025 ( GLOBE NEWSWIRE ) -- Cue Biopharma, Inc. ( Nasdaq: CUE ) , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease and cancer, today ...

Source: www.globenewswire.com
May 05, 2025 | 14:00:00
Category: News

© Natavest 2025 - 2026